Microbes and Respiratory Illnesses
Launched by UNIVERSITY OF WISCONSIN, MADISON · Sep 22, 2023
Trial Information
Current as of August 21, 2025
Recruiting
Keywords
ClinConnect Summary
The Microbes and Respiratory Illnesses (MARI) Study is looking into how exposure to different types of microbes on farms might help children develop healthier immune systems. Researchers believe that being around these microbes can lower the risk of getting severe colds, asthma, and allergies. The study is currently recruiting children aged 4 to 12 years, including those from Plain communities and the Madison area. There are specific groups of children being sought: those diagnosed with asthma, those without asthma, and those currently experiencing a respiratory illness.
To participate, children need to be in the right age range and meet certain criteria, such as having a parent or guardian who can give consent. Participants will undergo assessments related to their respiratory health, and the study aims to understand the relationship between microbes and respiratory conditions better. It's important to note that children with certain health issues, like chronic sinus infections, or who are planning to move away before the study is complete won't be eligible. Overall, this study is an exciting opportunity to learn more about how our environment affects children's health.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Participant and/or parent guardian must be able to understand and provide informed consent
- • 2. Children ages 4-12 years of age
- • 3. Cohort 1: Family is self-identified as Traditional agrarian (TA) Community member
- • 4. Cohort 2: Madison-area children with parental report of doctor-diagnosed asthma
- • 5. Cohort 3: Madison-area children with no history of asthma by parental report
- • 6. Cohort 4: Madison-area children who have an active respiratory illness
- Exclusion Criteria:
- • 1. Inability or unwillingness of a participant to give written informed consent or comply with study protocol
- • 2. Chronic sinusitis (frequent sinus infections)
- • 3. Plans to move out of the area before completing the study
- • 4. Past or current medical problems or findings from physical examination or laboratory testing that are not listed above, which, in the opinion of the investigator, may pose additional risks from participation in the study, may interfere with the participant's ability to comply with study requirements or that may impact the quality or interpretation of the data obtained from the study
- • 5. Enrolled family member
About University Of Wisconsin, Madison
The University of Wisconsin-Madison is a leading research institution renowned for its commitment to advancing healthcare through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university leverages its extensive resources, including cutting-edge facilities and a diverse pool of expert researchers, to conduct rigorous studies that address critical health challenges. The institution's focus on translating research findings into practical applications fosters the development of new treatments and interventions, ultimately contributing to improved patient outcomes and public health initiatives. As a sponsor of clinical trials, the University of Wisconsin-Madison is dedicated to upholding the highest ethical standards and ensuring participant safety throughout the research process.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Madison, Wisconsin, United States
Patients applied
Trial Officials
James Gern, MD
Principal Investigator
UW Madison
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported